Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 11 results:
Author [ Title(Desc)] Type Year
Filters: Author is Gunnell, D.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
C. Martinez, Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., and Gunnell, D., “Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study”, Bmj, vol. 330, p. 389, 2005.
I
B. Mars, Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., and Gunnell, D., “Influences on antidepressant prescribing trends in the UK: 1995-2011”, Soc Psychiatry Psychiatr Epidemiol, vol. 52, pp. 193-200, 2017.
P
N. M. Davies, Gunnell, D., Thomas, K. H., Metcalfe, C., Windmeijer, F., and Martin, R. M., “Physicians' prescribing preferences were a potential instrument for patients' actual prescriptions of antidepressants”, J Clin Epidemiol, vol. 66, pp. 1386-96, 2013.
R. M. Martin, Hemingway, H., Gunnell, D., Karsch, K. R., Baumbach, A., and Frankel, S., “Population need for coronary revascularisation: are national targets for England credible?”, Heart, vol. 88, pp. 627-33, 2002.
B. Mars, Heron, J., Gunnell, D., Martin, R. M., Thomas, K. H., and Kessler, D., “Prevalence and patterns of antidepressant switching amongst primary care patients in the UK”, J Psychopharmacol, vol. 31, pp. 553-560, 2017.
R
G. Geulayov, Ferrey, A., Casey, D., Wells, C., Fuller, A., Bankhead, C., Gunnell, D., Clements, C., Kapur, N., Ness, J., Waters, K., and Hawton, K., “Relative toxicity of benzodiazepines and hypnotics commonly used for self-poisoning: An epidemiological study of fatal toxicity and case fatality”, J Psychopharmacol, vol. 32, pp. 654-662, 2018.
A. E. Ferrey, Geulayov, G., Casey, D., Wells, C., Fuller, A., Bankhead, C., Ness, J., Clements, C., Gunnell, D., Kapur, N., and Hawton, K., “Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning”, BMC Psychiatry, vol. 18, p. 399, 2018.
K. H. Thomas, Davies, N. M., Taylor, A. E., Taylor, G. M. J., Gunnell, D., Martin, R. M., and Douglas, I., “Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-crossover study”, Addiction, 2020.
S
K. H. Thomas, Martin, R. M., Davies, N. M., Metcalfe, C., Windmeijer, F., and Gunnell, D., “Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study”, Bmj, vol. 347, p. f5704, 2013.
V
K. H. Thomas, Davies, N., Metcalfe, C., Windmeijer, F., Martin, R. M., and Gunnell, D., “Validation of suicide and self-harm records in the Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 76, pp. 145-57, 2013.
D. Gunnell, Irvine, D., Wise, L., Davies, C., and Martin, R. M., “Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database”, Bmj, vol. 339, p. b3805, 2009.
[Page last reviewed 6 April 2021]